SARS-CoV-2 is the virus that causes the COVID-19 disease (Coronovirus Disease 2019). Currently, this disease is poorly understood. Many researchers are working tirelessly to characterize this disease as well as researching treatments and/or cures, including finding a safe and effective vaccine.
T-cells are activated only by interacting with processed peptides (e.g. of SARS-CoV-2) that sit in the groove of MHC Class I and II molecules. Identifying these peptides can be used (in forms of peptide-MHC tetramers) to assess vaccine induced immunity and assist in designing potent vaccines with durable responses. COVID-19 infected cells can be recognized by T-cells only after SARS-CoV-2 peptides are processed and presented in the context of self MHCs.
MBL International is happy to assist companies and academic investigators who are actively characterizing this disease infection or developing coronavirus vaccines. We offer a vast number of peptides referenced in publications to have relevance in the immune detection pathway. We also offer RT-PCR Kit and RNA Extraction Kits.